Evidence map›Paper›PMID 35062242›Full record

ArticleViruses2021

A Replication-Competent HIV Clone Carrying GFP-Env Reveals Rapid Env Recycling at the HIV-1 T Cell Virological Synapse.

Lili Wang, Alice Sandmeyer, Wolfgang Hübner, Hongru Li, Thomas Huser, Benjamin K Chen

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Mechanisms of HIV-1 assembly, release and maturation.Nature reviews. Microbiology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Cell-cell communication: new insights and clinical implications.Signal transduction and targeted therapy · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lili WangDepartment of Medicine, Division of Infectious Disease, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Alice SandmeyerBiomolecular Photonics, Department of Physics, University of Bielefeld, 33615 Bielefeld, Germany.
Wolfgang HübnerBiomolecular Photonics, Department of Physics, University of Bielefeld, 33615 Bielefeld, Germany.
Hongru LiDepartment of Medicine, Division of Infectious Disease, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Thomas HuserBiomolecular Photonics, Department of Physics, University of Bielefeld, 33615 Bielefeld, Germany.
Benjamin K ChenDepartment of Medicine, Division of Infectious Disease, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-5404-1997
Bielefeld University · DEIcahn School of Medicine at Mount Sinai · US

Funding

HIV immune evasion and escape through T cell virological synapsesR37AI148064 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BENJAMIN K CHEN · 2022 to 2026
$3.1M
Cell migration and virological synapse formation in parenteral HIV transmissionR01DA041765 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHEN, BENJAMIN K · 2016 to 2020
$2.1M
Mechanisms of efficient HIV infection through T cell virological synapsesR01GM113885 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHEN, BENJAMIN K · 2014 to 2017
$1.7M
HIV immune evasion and escape through T cell virological synapsesR56AI148064 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHEN, BENJAMIN K · 2020 to 2020
$538k
NIAID NIH HHS R37 AI148064NIAID NIH HHS R56 AI148064NIDA NIH HHS R01 DA041765NIGMS NIH HHS R01 GM113885
6 · The paper itself

Abstract

HIV-1 infection is enhanced by cell-cell adhesions between infected and uninfected T cells called virological synapses (VS). VS are initiated by the interactions of cell-surface HIV-1 envelope glycoprotein (Env) and CD4 on target cells and act as sites of viral assembly and viral transfer between cells. To study the process that recruits and retains HIV-1 Env at the VS, a replication-competent HIV-1 clone carrying an Env-sfGFP fusion protein was designed to enable live tracking of Env within infected cells. Combined use of surface pulse-labeling of Env and fluorescence recovery after photobleaching (FRAP) studies, enabled the visualization of the targeted accumulation and sustained recycling of Env between endocytic compartments (EC) and the VS. We observed dynamic exchange of Env at the VS, while the viral structural protein, Gag, was largely immobile at the VS. The disparate exchange rates of Gag and Env at the synapse support that the trafficking and/or retention of a majority of Env towards the VS is not maintained by entrapment by a Gag lattice or immobilization by binding to CD4 on the target cell. A FRAP study of an Env endocytosis mutant showed that recycling is not required for accumulation at the VS, but is required for the rapid exchange of Env at the VS. We conclude that the mechanism of Env accumulation at the VS and incorporation into nascent particles involves continuous internalization and targeted secretion rather than irreversible interactions with the budding virus, but that this recycling is largely dispensable for VS formation and viral transfer across the VS.

Indexed as

CD4-Positive T-LymphocytesCell AdhesionClone CellsEndocytosisgag Gene Products, Human Immunodeficiency VirusGene Products, envHEK293 CellsHIV-1HIV InfectionsHumansJurkat CellsSynapsesVirus AssemblyVirus Internalizationgag Gene Products, Human Immunodeficiency VirusGene Products, envendocytosisEnvfluorescence recovery after photobleaching FRAPGagGFPHIV-1virological synapse

Identifiers

PMID35062242
PMCPMC8781834
OpenAlexW4205729616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.